Back to companies

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Hanmi Science Co Ltd (Hanmi Science) is a pharmaceutical company. It carries out research, development, and commercialization of various active pharmaceutical ingredients, key intermediates, Cephalosporin APIs, Cephalosporin finished dosage forms in both prescription and over-the counter markets. Hanmi Science’s prescription drugs include antidepressant, NSAIDs, neuropathic pain, oral care, hair growth, anti-inflammatory, osteoporos and diabetes, among others. The company’s OTC drugs consist of NSAIDs, oral care, calcium supplement, myalgia, vitamins nutritional supplements, and hypnotics, among others. It operates through two business units as Hanmi Science and Hanmi Pharmaceutical. The company supplies its products across the world. Hanmi Science is headquartered in Hwaseong, Gyeonggi-do, South Korea.

Headquarters South Korea

Address 214, Muha-Ro, Paltan-Myeon, Hwaseong, 18536


Telephone 82 2 4100447

No of Employees 98

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 008930 ()

Revenue (2021) $830.5M 10.8% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX 90% (2021 vs 2020)

Market Cap* $2.0B

Net Profit Margin (2021) XXX 71.2% (2021 vs 2020)

* As of and is in US$

Explore premium data & analytics

270+

Clinical Trials

Determine Hanmi Science Co Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

260+

Marketed Drugs

Understand Hanmi Science Co Ltd’s commercialized product portfolio to stay one step ahead of the market.

130+

Pipeline Drugs

Identify which of Hanmi Science Co Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

100+

Catalyst Calendar

Proactively evaluate Hanmi Science Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

70+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Hanmi Science Co Ltd’s relevant decision makers and contact details.

20+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

18+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Hanmi Science Co Ltd and assess market opportunity for new entrants with patient population 8-year forecasts.

7

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products
Active Pharmaceutical Ingredients
Key Intermediates
Cephalosporin API's
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2021 Contracts/Agreements In October, the company and the University of Oxford entered into a partnership to prevent new and mutated infectious diseases.
2021 Contracts/Agreements In January, the company entered into a strategic collaboration with Syntekabio to co-develop COVID-19 treatments by using drug repositioning technologies.
2020 Contracts/Agreements In September, the company entered into an agreement with Merck to develop Efinopegdutide for the treatment of nonalcoholic steatohepatitis.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Hanmi Science Co Ltd Easy Bio Inc Chong Kun Dang Pharmaceutical Corp Daewoong Pharmaceutical Co Ltd JW Holdings Corp
Headquarters South Korea South Korea South Korea South Korea South Korea
City Hwaseong Seoul Seoul Hwaseong Seoul
No. of Employees 98 182 1,904 1,256 161
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Song Young-sook Chief Executive Officer; Director Executive Board 2020 -
Taeseon Kwak Director Non Executive Board 2022 -
Woo Jong-soo Director Non Executive Board 2020 -
Shin Yoo-chul Director Non Executive Board 2022 -
Kim Yong-deok Director Non Executive Board 2022 -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer